Phase 0 trial investigating the intra-tumoural concentration and activity of Sorafenib in Neurofibromatosis type 2

Sylvia Ammoun, D Gareth Evans, David Hilton, Adam Streeter, Christopher Hayward, C Oliver Hanemann

Research output: Contribution to journalArticlepeer-review

66 Downloads (Pure)
Original languageEnglish
JournalJournal of Neurology, Neurosurgery and Psychiatry
Early online date4 Feb 2019
Publication statusPublished - Feb 2019

Cite this